Home › Funds › GW&K Investment Management, LLC › VCYT
GW&K Investment Management, LLC position in VCYT
VERACYTE INC · Health Care
GW&K Investment Management, LLC reported holding 2,409,303 shares of VCYT (VERACYTE INC) in its Q3 2026 13F filing — a position valued at US$110.9M, representing 0.94% of its reported portfolio and ranking #9 among its reported holdings. GW&K Investment Management, LLC has disclosed VCYT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How GW&K Investment Management, LLC's VCYT position evolved
GW&K Investment Management, LLC first disclosed a stake in VCYT in Q3 2023 at 1,231,621 shares (US$27.5M). The position peaked in Q3 2026 at 2,409,303 shares, worth US$110.9M. Across 13 filings, GW&K Investment Management, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 2,409,303 shares valued at US$110.9M — an increase of 992,760 shares quarter over quarter.. Notable position changes include a 26% increase in Q1 2026 (shares rose 82% over the following quarter), a 70% increase in Q3 2026 (shares fell 47% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.23M | $27.50M | New |
| Q4 2023 | 1.42M | $38.93M | Add |
| Q1 2024 | 1.40M | $30.93M | Reduce |
| Q2 2024 | 1.41M | $30.45M | Add |
| Q3 2024 | 1.43M | $48.65M | Add |
| Q4 2024 | 1.21M | $48.00M | Reduce |
| Q1 2025 | 1.26M | $37.27M | Add |
| Q2 2025 | 1.40M | $37.97M | Add |
| Q3 2025 | 1.28M | $44.06M | Reduce |
| Q4 2025 | 1.14M | $48.00M | Reduce |
| Q1 2026 | 1.44M | $46.30M | Add |
| Q2 2026 | 1.42M | $83.19M | Reduce |
| Q3 2026 | 2.41M | $110.92M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VCYT and 13F data
VCYT (VERACYTE INC) is a Health Care company. 42 other funds we track also report a position in VCYT — the largest reported positions include ARK Invest (US$136.5M), OBERWEIS ASSET MANAGEMENT INC/ (US$51.5M), SEGALL BRYANT & HAMILL, LLC (US$37.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VCYT
- ARK Invest 2.96M sh · $136.49M · Q3 2026
- OBERWEIS ASSET MANAGEMENT INC/ 877.73K sh · $51.55M · Q2 2026
- SEGALL BRYANT & HAMILL, LLC 633.23K sh · $37.19M · Q2 2026
- ArrowMark Colorado Holdings LLC 441.99K sh · $25.96M · Q2 2026
More on GW&K Investment Management, LLC
FAQ
How long has GW&K Investment Management, LLC held VCYT?
GW&K Investment Management, LLC has disclosed VCYT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is GW&K Investment Management, LLC's current position in VCYT?
As of Q3 2026, GW&K Investment Management, LLC holds 2.41M shares of VCYT (VERACYTE INC), valued at $110.92M, representing 0.94% of its reported portfolio and ranking #9.
Has GW&K Investment Management, LLC been buying or selling VCYT?
In the latest 13F filing (Q3 2026), GW&K Investment Management, LLC increased its position in VCYT. The position peaked in Q3 2026 at 2.41M shares.
Which other funds hold VCYT?
Other major institutional holders of VCYT include ARK Invest, OBERWEIS ASSET MANAGEMENT INC/, SEGALL BRYANT & HAMILL, LLC, among 42 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.